You have 9 free searches left this month | for more free features.

Melphalan

Showing 1 - 25 of 911

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Newly Diagnosed Patients
  • Melphalan
  • +2 more
  • Torino, Italy
    Division of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • Melphalan and Treosulfan
  • Melphalan
  • (no location specified)
Dec 5, 2022

Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

Terminated
  • Amyloidosis; Systemic
  • Propylene Glycol-Free Melphalan Hydrochloride
  • Boston, Massachusetts
    Boston Medical Center
Jul 1, 2022

Multiple Myeloma Trial (RP followed by MPR)

Active, not recruiting
  • Multiple Myeloma
  • RP followed by MPR
  • (no location specified)
Mar 24, 2022

Multiple Myeloma Trial in Beijing (melphalan HCl for injection)

Recruiting
  • Multiple Myeloma
  • melphalan hydrochloride for injection
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 26, 2022

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Hematopoietic Stem Cell Transplantation Trial in Cincinnati (Melphalan)

Completed
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 24, 2021

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Melphalan
  • +3 more
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Melanoma, Ocular Trial in Tampa, Durham (Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS))

Available
  • Melanoma, Ocular
  • Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS)
  • Tampa, Florida
  • +1 more
Mar 23, 2022

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Hematopoietic Stem Cell Transplantation Trial in Seoul (Melphalan)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jun 23, 2021

Oral Mucositis in Patient's Undergoing Melphalan Conditioning

Withdrawn
  • Mucositis
  • +3 more
  • Melphalan kinetic study
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jan 6, 2022

Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell

Completed
  • Hematologic Malignancies
  • +7 more
  • Melphalan
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade

Active, not recruiting
  • Multiple Myeloma
  • velcade subcutaneous melphalan prednisone
  • +2 more
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022

Retinoblastoma, Chemo Effect Trial in Guangzhou (Topotecan, Melphalan)

Recruiting
  • Retinoblastoma
  • Chemotherapy Effect
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Mar 12, 2021

Multiple Myeloma Trial in Torino (Melphalan, Prednisone, Lenalidomide, Cyclophosphamide, Prednisone, Lenalidomide, Lenalidomide,

Active, not recruiting
  • Multiple Myeloma
  • Melphalan, Prednisone, Lenalidomide
  • +2 more
  • Torino, TO, Italy
    Division Of Hematology, A.O.U. Città della Salute e della Scienz
Mar 24, 2022

Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2022

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Aug 25, 2021

Renal Impairment, RRMM Trial in Czechia, Greece, Poland (Melphalan flufenamide (melflufen), Dexamethasone)

Terminated
  • Renal Impairment
  • RRMM
  • Brno, Czechia
  • +9 more
Feb 2, 2022

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Apr 28, 2022

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022